Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Surg Oncol. 2022 Mar;125(3):465-474. doi: 10.1002/jso.26731. Epub 2021 Oct 27.
Although high volume centers (HVC) equate to improved outcomes in rectal cancer, the impact of surgical volume related to race is less defined.
Patients who underwent surgical resection for stage I-III rectal adenocarcinoma were divided into cohorts based on race and hospital surgical volume. Outcomes were analyzed following 1:1 propensity-score matching using logistic, Poisson, and Cox regression analyses with marginal effects.
Fifty-four thousand one hundred and eighty-four (91.5%) non-Black and 5043 (8.5%) Black patients underwent resection of rectal cancer. Following 1:1 matching of non-Black (N = 5026) and Black patients, 5-year overall survival (OS) of Black patients was worse (72% vs. 74.4%, average marginal effects [AME] 0.66, p = 0.04) than non-Black patients. When compared to non-Black patients managed at HVCs, Black patients had worse OS (70.1% vs. 74.7%, AME 1.55, p = 0.03), but this difference was not significant when comparing OS between non-Black and Black patients managed at HVCs (72.3% vs. 74.7%, AME 0.62, p = 0.06). Length of stay was longer among Black and HVC patients across all cohorts. There was no difference across cohorts in 90-day mortality.
Although racial disparities exist in rectal cancer, this disparity appears to be ameliorated when patients are managed at HVCs.
尽管高容量中心(HVC)与直肠癌的改善结果相关,但与种族相关的手术量的影响尚未明确。
根据种族和医院手术量,将接受 I-III 期直肠腺癌手术切除的患者分为队列。使用逻辑、泊松和 Cox 回归分析以及边缘效应进行 1:1 倾向评分匹配后,分析结果。
54184 名(91.5%)非黑人患者和 5043 名(8.5%)黑人患者接受了直肠癌切除术。在对非黑人(N=5026)和黑人患者进行 1:1 匹配后,黑人患者的 5 年总生存率(OS)较差(72% vs. 74.4%,平均边缘效应[AME]为 0.66,p=0.04)。与在 HVC 治疗的非黑人患者相比,黑人患者的 OS 较差(70.1% vs. 74.7%,AME 为 1.55,p=0.03),但在比较 HVC 治疗的非黑人患者和黑人患者的 OS 时,这一差异无统计学意义(72.3% vs. 74.7%,AME 为 0.62,p=0.06)。在所有队列中,黑人患者和 HVC 患者的住院时间均较长。各队列的 90 天死亡率无差异。
尽管直肠癌存在种族差异,但当患者在 HVC 治疗时,这种差异似乎得到了改善。